wpeebb6edf.png

pharmaceutical business development

CASE STUDIES

OUR SERVICES

A Romanian pharmaceutical company wanted business development support. Find out how we helped >>

 

A university wanted a commercial appraisal and valuation of an antibody technology. Find out more >>

 

A biotech company’s business development resources were stretched. Find out how we provided interim management support >>

 

The Government of Egypt wanted a thorough strategic review and benchmarking of their pharmaceutical industry. Find out more >>

 

More case studies >>

wp4d260c75_0f.jpg
wp4d0b2b68.png
wpf15fc759.gif

© Estradia Consulting Limited, 2004-2009                                 Tel:  + 44 (0) 1252 714221                                                                   info@estradia.co.uk

 

wp7e88b104.png
wp978d2d37.png
wp0b81fced.png
wpb1b233a5.png
wpe4889b74.png
wp26f79f53.png
wp8c0540a4.png
wp4d0b2b68.png
wp2e0e51b9.gif

RECENT PROJECTS

 

We have worked with many international clients ranging from individual entrepreneurs and small companies through to pharmaceutical companies and governments.  We always strive to add value with what we do and only take on projects where we have the experience and skills required.  Below are some examples of recent projects.

 

Case Study 5

 

An entrepreneur wanted to raise money to start a new respiratory products company.  She was an experienced medical doctor but had limited business skills.

 

We worked with her to help her to prepare a robust business plan, to budget for the business start-up and to plan for the longer term development of the business.

 

Case Study 6

 

A small early stage company developing a novel vaccine technology wanted advice on the licensing terms for allowing manufacturers to access their technology.

 

We prepared a draft licensing agreement for the company highlighting the areas that they needed to focus on during their negotiations with manufacturers. Through our extensive contacts in the international licensing field we were able to benchmark expected fees for technology access.

 

More Case Studies >>

 

<< Back to previous Case Studies